Biotech ends summer on a high

Biotech finished on a high in August, according to San Francisco venture capital firm Burrill & Company.

The company’s Burrill Biotech Select Index closed up 4.4 percent on Friday before the Labor Day holiday weekend, said G. Steven Burrill, company CEO.

Top performers included Emeryville’s Onyx Pharmaceuticals (ONXX), up 42 percent, and Vertex Pharmaceuticals, up 21 percent.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/
Previous story
Oracle to acquire Ireland's Netsure
Next story
Business briefs: 'Second Life' crisis

Just Posted

Music venue owners warn ‘hospitality and entertainment are dying’

Industry leaders plead with city, state for help

Advocates call for permanent moratorium on ‘poverty tows’

Ron Trathen hates change. He recalls moving around a lot as a… Continue reading

Anti-police protester sues over arrest at 2019 Pride Parade

A protester whose arrest at San Francisco’s 2019 Pride Parade intensified pressure… Continue reading

Veritas offers to forgive unpaid rent, but tenants are wary

Calls for rent forgiveness have been answered, but with some caveats. The… Continue reading

Dozens gather for candlelight vigil to honor victims in Beirut explosion

Dozens of people gathered at Rincon Park on Thursday evening to show… Continue reading

Most Read